Search

Your search keyword '"Brokamp, Elly"' showing total 132 results

Search Constraints

Start Over You searched for: Author "Brokamp, Elly" Remove constraint Author: "Brokamp, Elly"
132 results on '"Brokamp, Elly"'

Search Results

1. Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome (NODRS)

2. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

3. Heterozygous rare variants in NR2F2 cause a recognizable multiple congenital anomaly syndrome with developmental delays

4. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

5. De novo variants in DENND5B cause a neurodevelopmental disorder

6. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

7. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

8. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.

9. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

10. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

11. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

12. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy.

13. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects

14. Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis

15. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

16. Understanding Adult Participant and Parent Empowerment Prior to Evaluation in the Undiagnosed Diseases Network.

18. De novo variants in DENND5B cause a neurodevelopmental disorder

19. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

20. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

21. GABRA1-related disorders:from genetic to functional pathways

22. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

23. Next-generation phenotyping: introducing phecodeX for enhanced discovery research in medical phenomics

24. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

25. GABRA1‐Related Disorders: From Genetic to Functional Pathways

26. Practical considerations for reinterpretation of individual genetic variants

27. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

28. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

32. Heterozygous rare variants in NR2F2cause a recognizable multiple congenital anomaly syndrome with developmental delays

34. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

35. One is the loneliest number: genotypic matchmaking using the electronic health record

36. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

37. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

38. Histone H3.3 beyond cancer : Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients

39. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

40. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

41. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

42. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

43. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region

44. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

45. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts

46. A description of novel variants and review of phenotypic spectrum in UBA5-related early epileptic encephalopathy.

47. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

48. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

49. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

Catalog

Books, media, physical & digital resources